Treatment tactics for gastrointestinal bleeding following percutaneous coronary intervention for myocardial infarction with development of no-reflow syndrome (clinical case)
Автор: Kosheleva N.A., Kharlamov V.E., Kashkina E.I.
Журнал: Саратовский научно-медицинский журнал @ssmj
Рубрика: Кардиология
Статья в выпуске: 3 т.17, 2021 года.
Бесплатный доступ
This clinical case demonstrates that percutaneous coronary intervention indicated in the treatment of ST-segment elevation myocardial infarction. Successful percutaneous coronary intervention may result in no-reflow syndrome. Drug therapy of myocardial infarction with ST segment elevation and no-reflow syndrome is accompanied by the introduction of a large number of antithrombotic drugs. The prescription of triple antiplatelet, anticoagulant therapy significantly increases the risk of gastrointestinal bleeding, especially in patients with a history of ulcer disease. The practitioner doctor being prepared for such a complication of this therapy, take timely measures to stop it, and use proton pump inhibitors for the purpose of gastroprotection
Myocardial infarction, percutaneous coronary intervention, gastrointestinal bleeding.
Короткий адрес: https://sciup.org/149138135
IDR: 149138135